Not yet recruiting
Lung assist device therapy
Not yet recruitingComparing low-dose and standard-dose argatroban or enoxaparin to prevent blood clots in patients with heart or lung failure receiving extracorporeal membrane oxygenation.
Registered drugNo placebo
Comparing low-dose and standard-dose argatroban or enoxaparin to prevent blood clots in patients with heart or lung failure receiving extracorporeal membrane oxygenation.
Registered drugNo placebo
- Disease:Lung assist device therapy
- Substances:Enoxaparin SodiumArgatroban Monohydrate
Countries:
Czechia
Czechia- Participants:18–64 years · 65+ years
- Substances:Enoxaparin Sodium
- Sponsor:Fakultni Nemocnice Ostrava